Chicago, Illinois, United States The company was established in North America in United States. The main office of represented VC is situated in the Chicago.
The real fund results show that this VC is 6 percentage points less often commits exit comparing to other companies. Deals in the range of 1 - 5 millions dollars are the general things for fund. This Helix Fund works on 0 percentage points less the average amount of lead investments comparing to the other organizations. The top amount of exits for fund were in 2017. The high activity for fund was in 2015. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 deals per year.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Biotechnology, Life Science. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight MediBeacon, Euclises Pharmaceuticals, Arvegenix.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Helix Fund, startups are often financed by St. Louis Arch Angels, Missouri Technology Corporation, Cultivation Capital. The meaningful sponsors for the fund in investment in the same round are BioGenerator, Missouri Technology Corporation, Cultivation Capital. In the next rounds fund is usually obtained by Cultivation Capital, St. Louis Arch Angels, Missouri Technology Corporation.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Atlantic Innovation Fund | - |
| D.Z Capital | Beijing, Beijing, China |
| M.M. Dillon & Co. | Connecticut, Greenwich, United States |
| NISSHO ELECTRONICS | Japan, Tokyo |
| Nordic technology investment fund | - |
| Rogers Corporation | Connecticut, Rogers, United States |
| SBT fund | - |
| Sugar Mountain | Seattle, United States, Washington |
| Triton Funds LLC | California, Los Angeles, United States |
| Windforce Ventures | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Mentor Spaces | $200K | 02 Jun 2017 | Denver, Colorado, United States | ||
Covercress | $2M | 11 May 2015 | City of Saint Louis, Missouri, United States | ||
SynerZ Medical | $650K | 24 Feb 2015 | St Louis, Missouri, United States | ||
Euclises Pharmaceuticals | $1M | 09 Sep 2014 | City of Saint Louis, Missouri, United States | ||
Confluence Life Sciences | $4M | 17 Sep 2012 | City of Saint Louis, Missouri, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Mentor Spaces | $200K | 02 Jun 2017 | Denver, Colorado, United States | ||
Covercress | $2M | 11 May 2015 | City of Saint Louis, Missouri, United States | ||
SynerZ Medical | $650K | 24 Feb 2015 | St Louis, Missouri, United States | ||
Euclises Pharmaceuticals | $1M | 09 Sep 2014 | City of Saint Louis, Missouri, United States | ||
Confluence Life Sciences | $4M | 17 Sep 2012 | City of Saint Louis, Missouri, United States |
